Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sunshine Biopharma (SBFM) Tax Provisions (2022 - 2025)

Sunshine Biopharma's Tax Provisions history spans 4 years, with the latest figure at $408374.0 for Q4 2025.

  • For Q4 2025, Tax Provisions rose 417.22% year-over-year to $408374.0; the TTM value through Dec 2025 reached $21609.0, up 109.2%, while the annual FY2025 figure was $21609.0, 109.2% up from the prior year.
  • Tax Provisions reached $408374.0 in Q4 2025 per SBFM's latest filing, up from -$137438.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $408374.0 in Q4 2025 to a low of -$343691.0 in Q2 2024.
  • Average Tax Provisions over 4 years is $31940.1, with a median of $40952.0 recorded in 2023.
  • The largest YoY upside for Tax Provisions was 425.53% in 2024 against a maximum downside of 492.0% in 2024.
  • A 4-year view of Tax Provisions shows it stood at $233304.0 in 2022, then decreased by 5.59% to $220267.0 in 2023, then tumbled by 158.45% to -$128737.0 in 2024, then soared by 417.22% to $408374.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Tax Provisions are $408374.0 (Q4 2025), -$137438.0 (Q3 2025), and -$209166.0 (Q2 2025).